Literature DB >> 11756710

Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 U.S. residents.

Giuseppe Brancatelli1, Michael P Federle, Luigi Grazioli, Brian I Carr.   

Abstract

PURPOSE: To review clinical, pathologic, and computed tomographic (CT) findings in patients with hepatocellular carcinoma (HCC) in noncirrhotic liver.
MATERIALS AND METHODS: Clinical, pathologic, and imaging findings were retrospectively evaluated in 39 patients with HCC in noncirrhotic liver. Helical multiphasic CT scans obtained with 125 mL of contrast medium at a rate of 4 or 5 mL/sec were reviewed for morphologic features such as tumor size, margins, and hemorrhage and degree of enhancement.
RESULTS: All patients (25 men, 14 women; mean age, 61 years) were U.S. residents; none had an Asian surname. Twenty-four patients (62%) had no identifiable risk factors; 34 (87%) were symptomatic. HCC was proved and cirrhosis excluded with biopsy in all cases. HCC was moderately (n = 32) or well (n = 6) differentiated in 97% of cases and poorly differentiated in one. Serum alpha-fetoprotein level was elevated in 26 patients. Large tumors (mean diameter, 12.4 cm) were depicted at CT in all cases. Thirty-two patients had a solitary or dominant mass. At CT, tumor margins were well defined in 21 patients, with a lobulated surface in 33. Calcifications were depicted in 11, hemorrhage in 10, fat in four, dilated intrahepatic bile ducts in 17, and abdominal lymphadenopathy in eight. In 38 patients, tumors were heterogeneous with areas of necrosis. HCC was hypoattenuating on nonenhanced images in 34, heterogeneously hyperattenuating at arterial phase in 38, and hypoattenuating at portal phase in 35 patients.
CONCLUSION: HCC developed in the absence of cirrhosis or known risk factors and typically appeared as a large symptomatic hepatic tumor with clinical, laboratory, and CT features that distinguish it from most other hepatic masses.

Entities:  

Mesh:

Year:  2002        PMID: 11756710     DOI: 10.1148/radiol.2221010767

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  Hepatocellular carcinoma (HCC) in non-cirrhotic liver: clinical, radiological and pathological findings.

Authors:  Michele Di Martino; Luca Saba; Sandro Bosco; Massimo Rossi; Kirchin A Miles; Rossella Di Miscio; Concetta Valentina Lombardo; Elisabetta Tamponi; Mario Piga; Carlo Catalano
Journal:  Eur Radiol       Date:  2014-04-26       Impact factor: 5.315

2.  Noncirrhotic hepatocellular carcinoma: derivation from hepatocellular adenoma? Clinicopathologic analysis.

Authors:  Ta-Chiang Liu; Neeta Vachharajani; William C Chapman; Elizabeth M Brunt
Journal:  Mod Pathol       Date:  2013-09-20       Impact factor: 7.842

Review 3.  Imaging of liver cancer.

Authors:  Ben Ariff; Claire R Lloyd; Sameer Khan; Mohamed Shariff; Andrew V Thillainayagam; Devinder S Bansi; Shahid A Khan; Simon D Taylor-Robinson; Adrian K P Lim
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

4.  Risk profile of hepatocellular carcinoma reveals dichotomy among US veterans.

Authors:  Raffi Karagozian; Errol Baker; Antoun Houranieh; Daniel Leavitt; György Baffy
Journal:  J Gastrointest Cancer       Date:  2013-09

5.  Breast metastases from extramammary malignancies: typical and atypical ultrasound features.

Authors:  Sung Hee Mun; Eun Young Ko; Boo-Kyung Han; Jung Hee Shin; Suk Jung Kim; Eun Yoon Cho
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

6.  Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions.

Authors:  Josephina A Vossen; Manon Buijs; Eleni Liapi; John Eng; David A Bluemke; Ihab R Kamel
Journal:  J Comput Assist Tomogr       Date:  2008 Sep-Oct       Impact factor: 1.826

7.  Chemoembolization of intermediate stage hepatocellular carcinomas: results from a Nordic tertiary liver cancer center.

Authors:  Kasper J Andersen; Henning Grønbaek; Gerda Elisabeth Villadsen; Anders Riegels Knudsen; Peter Ott; Hendrik Vildstrup; Dennis Tønner Nielsen; Arindam Bharadwaz
Journal:  Indian J Gastroenterol       Date:  2013-12-04

8.  Yttrium-90 Radioembolization and Tumor Hypoxia: Gas-challenge BOLD Imaging in the VX2 Rabbit Model of Hepatocellular Carcinoma.

Authors:  Andrew C Gordon; Sarah B White; Vanessa L Gates; Daniel Procissi; Kathleen R Harris; Yihe Yang; Zhuoli Zhang; Weiguo Li; Tianchu Lyu; Xiaoke Huang; Reed A Omary; Riad Salem; Robert J Lewandowski; Andrew C Larson
Journal:  Acad Radiol       Date:  2020-06-07       Impact factor: 5.482

9.  Characterization of incidental liver lesions: comparison of multidetector CT versus Gd-EOB-DTPA-enhanced MR imaging.

Authors:  Yong Eun Chung; Myeong-Jin Kim; Yeo-Eun Kim; Mi-Suk Park; Jin Young Choi; Ki Whang Kim
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

10.  Primary hepatic neuroendocrine tumor: gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging.

Authors:  Soo-Heui Baek; Jung-Hee Yoon; Kwan-Woo Kim
Journal:  Acta Radiol Short Rep       Date:  2013-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.